top of page

PHARMACEUTICALS

Newsroom

Feb 20

DelAQUA Pharmaceuticals Achieves Remarkably High Oral Bioavailability for Poorly Soluble Compounds using Solubilizing Poly(2-oxazoline) Triblock Copolymers

Feb 6

DelAQUA Pharmaceuticals and Oxaphil GmbH Announce Strategic Collaboration

Jan 30

Particle Sciences Inc. and DelAQUA Pharmaceuticals Announce Strategic Collaboration

bottom of page